About

Dr. Livio Presutti is a leading figure in head and neck surgical oncology, with a focused expertise in transoral robotic surgery (TORS) for complex aerodigestive tract malignancies. His major contributions center on advancing minimally invasive techniques to preserve critical functions—such as speech and swallowing—while maintaining rigorous oncologic outcomes. In his landmark 2024 systematic review (22 citations), Dr. Presutti comprehensively evaluated functional results after TORS for oropharyngeal squamous cell carcinoma, establishing benchmarks for postoperative quality of life. He has also pioneered the application of TORS beyond traditional indications, including a 2017 study (15 citations) demonstrating its feasibility for anterior cervical spine lesions, and a 2025 comparative analysis (6 citations) of robotic approaches for parapharyngeal space tumors. His 2024 systematic review on temporary tracheotomy predictors in supraglottic cancer patients (8 citations) further refines perioperative risk stratification. Dr. Presutti’s work has been instrumental in defining evidence-based protocols that reduce morbidity and expand the scope of robotic surgery, earning him recognition as a key innovator in functional preservation and surgical precision. His research continues to shape clinical guidelines and inspire next-generation head and neck surgeons.

Research Focus

Key Achievements

4
H-Index
4
Papers
51
Total Citations
13
Avg Citations/Paper
🏆 Most Cited Paper
A Comprehensive Systematic Review on Functional Results, Speech and Swallowing Outcomes after Trans-Oral Robotic Surgery for Oropharyngeal Squamous Cell Cancer
22 citations · 2024
📈 Most Prolific Year: 2024 (2 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Azienda USL di Bologna, Azienda Ospedaliero-Universitaria di Modena, IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago